ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Notably, BCAT1 promotes BCAA production in BCR-ABL driven chronic myelogenous leukemia, in which BCAT1 blockade impairs B-cell proliferation and causes differentiation77.